It's not surprising that drug makers oppose Maryland's efforts to limit prices of some prescription drugs, write Sean Tunis ...

Shares of pharmaceutical giant Amgen (AMGN) are attempting to bounce back after suffering a steep drop of 7.1% yesterday.

The Act curbs US-China biotech collaborations, spurring opportunities for emerging markets in pharma supply chains.

AbbVie’s deal flop and NFL high-profile draft busts have a lot in common.

STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.

Shares of Medicus Pharma tumbled 39%, to $2.50, on the company's first day of trading Thursday. The biotechnology and life-sciences pharmaceutical company on Wednesday said it would sell 970,000 units ...

Mankind Pharma announced the pledge of nearly 40 per cent of its wholly-owned subsidiary, Bharat Serums and Vaccines Limited, ...

The company behind ChatGPT didn’t set out to tackle health care. But despite ongoing concerns about its technology’s tendency ...

This health news summary explores various pharmaceutical developments including Novo Nordisk's phasing out of insulin pens, a ...

The clinical stage biopharmaceutical company is developing inhaled drug delivery devices. Transpire Bio expands headquarters ...

JB Pharma, Sun, Torrent ,Lupin, Abbott, Glenmark, Dr Reddy's Cipla, Zydus remained among Key pharma market growth drivers in ...

Nuvectis Pharma shares fell steeply after updated data from its early-stage study evaluating NXP800 to treat an aggressive type of ovarian cancer showed that a change in the dosing schedule only ...